Macrovascular complication phenotypes in type 2 diabetic patients.
about
BCL11A gene DNA methylation contributes to the risk of type 2 diabetes in malesProtein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy.Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study.Metabolic syndrome for sub-Saharan Africans diabetes with peripheral arterial disease: a case-control studyType 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathyCombined influence of nonalcoholic fatty liver and body size phenotypes on diabetes riskPredictors and prevention of diabetic cardiomyopathy.Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients.Relationship of obesity and insulin resistance with the cerebrovascular reactivity: a case control studyAssociation of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathyStandardized screening for periodontitis as an integral part of multidisciplinary management of adults with type 2 diabetes: an observational cross-sectional study of cohorts in the USA and UK.Advanced Interfere Treatment of Diabetic Cardiomyopathy Rats by aFGF-Loaded Heparin-Modified Microbubbles and UTMD Technique.Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.The present and future role of ultrasound targeted microbubble destruction in preclinical studies of cardiac gene therapy.ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus
P2860
Q33837435-291D1F4F-B756-4C7C-B507-4F7A243630A4Q34252960-CF25F7EF-E5B1-4B93-BD95-5FF80DA0319BQ34503055-D73F7195-C5AD-4E29-98B3-88BB822EBD81Q35101873-5B555841-90BA-4601-8A04-56C4767BB3FDQ35317010-9455195F-B109-4A36-932B-FA2F750D56D3Q36222629-566AC185-5390-4907-B87F-8F449E49F619Q36776922-FDA4A2A7-16DB-4741-8C95-A94C604D3F6AQ37292061-803843C0-FEE3-4E51-B76E-FC38A08F233BQ37439483-0C6199E4-3285-4770-86FF-027120A8382CQ37569809-B99D7EEA-A8F1-48EA-B252-0508AEA7ECEDQ38650396-B786D9F0-25BC-48E1-ABD2-D4D928E908CAQ38899271-EEAE266F-0C30-40F0-9699-5B95874E9985Q50179665-93C6F81C-A43F-4752-80A8-576205FDBE2EQ55055161-5A9D88EE-7816-476A-A3A6-54A1978D8F63Q58727846-9DA7636B-2809-4E6E-A2FF-BCED5D43CEAD
P2860
Macrovascular complication phenotypes in type 2 diabetic patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Macrovascular complication phenotypes in type 2 diabetic patients.
@ast
Macrovascular complication phenotypes in type 2 diabetic patients.
@en
type
label
Macrovascular complication phenotypes in type 2 diabetic patients.
@ast
Macrovascular complication phenotypes in type 2 diabetic patients.
@en
prefLabel
Macrovascular complication phenotypes in type 2 diabetic patients.
@ast
Macrovascular complication phenotypes in type 2 diabetic patients.
@en
P2093
P2860
P356
P1476
Macrovascular complication phenotypes in type 2 diabetic patients.
@en
P2093
Carmelo Licciardello
Claudia Degano
Concetta Finocchiaro
Giuseppe Papa
Maria P Iurato
Raffaella Maiorana
P2860
P2888
P356
10.1186/1475-2840-12-20
P407
P577
2013-01-18T00:00:00Z
P5875
P6179
1040768415